ergonovine has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hollenberg, NK; Humphrey, WR; Orlandi, C; Schaub, RG | 1 |
| Angus, JA; Cocks, TM; Kemp, BK; Pruneau, D | 1 |
2 other study(ies) available for ergonovine and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
In vivo demonstration of enhanced arterial constrictor response to serotonin following focal endothelial cell loss.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Dogs; Endothelium, Vascular; Ergonovine; Female; Femoral Artery; Male; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Norepinephrine; Pressure; Prostaglandin Endoperoxides, Synthetic; Serotonin; Vasoconstriction | 1990 |
Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Coronary Vessels; Drug Synergism; Ergonovine; Humans; In Vitro Techniques; Isometric Contraction; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents | 1993 |